Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1375301-91-9 | MDL No. : | MFCD12032616 |
Formula : | C13H19BN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DVGWUOHIWJBHKY-UHFFFAOYSA-N |
M.W : | 246.11 | Pubchem ID : | 45787283 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.69 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 70.97 |
TPSA : | 44.24 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.54 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.77 |
Log Po/w (WLOGP) : | 1.59 |
Log Po/w (MLOGP) : | 0.69 |
Log Po/w (SILICOS-IT) : | 1.74 |
Consensus Log Po/w : | 1.16 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.6 |
Solubility : | 0.624 mg/ml ; 0.00254 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.32 |
Solubility : | 1.19 mg/ml ; 0.00482 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.86 |
Solubility : | 0.0342 mg/ml ; 0.000139 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.08 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39% | at 90℃; for 16 h; | A mixture of 12A(0.8 g, 4.02 mmol), Pd(dppf)C12 (147 mg, 0.20 mmol), KOAc (592 mg, 6.03 mmol) and bis(pinacolato)diboron (1.16 g, 4.82 mmol) in dioxane (20 mL) was heated to 90° C. overnight. After cooling, the reaction mixture was concentrated and the residue was purified by silica gel column chromatography (1/50 to 1/10 ethyl acetate/pet. ether) to give 12B (0.38 g, 39percent yield) as a yellow solid: ESI mlz 247.1 [M+H]. |
[ 1052686-67-5 ]
2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Similarity: 0.91
[ 321724-19-0 ]
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Similarity: 0.83
[ 402960-38-7 ]
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
Similarity: 0.77
[ 1003845-08-6 ]
2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Similarity: 0.74
[ 1052686-60-8 ]
2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Similarity: 0.73
[ 1052686-67-5 ]
2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Similarity: 0.91
[ 321724-19-0 ]
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Similarity: 0.83
[ 402960-38-7 ]
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
Similarity: 0.77
[ 1003845-08-6 ]
2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Similarity: 0.74
[ 1052686-60-8 ]
2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Similarity: 0.73